| scholarly article | Q13442814 |
| P50 | author | Adrian V. S. Hill | Q22278197 |
| Sarah Gilbert | Q30513802 | ||
| Alexandra Spencer | Q43158244 | ||
| Matthew G. Cottingham | Q55465134 | ||
| Efrain Guzman | Q56841961 | ||
| Bryan Charleston | Q61162596 | ||
| P2093 | author name string | Matthew D J Dicks | |
| P2860 | cites work | Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates | Q27306708 |
| A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity | Q28727030 | ||
| Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors | Q28731894 | ||
| Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1 | Q28743564 | ||
| HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
| Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major | Q29619125 | ||
| Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial | Q29620144 | ||
| T-cell quality in memory and protection: implications for vaccine design | Q30014840 | ||
| Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine | Q30429455 | ||
| Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). | Q33320536 | ||
| Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates | Q33478399 | ||
| Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses | Q33652450 | ||
| Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. | Q34119135 | ||
| Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae | Q34178208 | ||
| Adenoviruses as vaccine vectors | Q34353523 | ||
| SPICE: exploration and analysis of post-cytometric complex multivariate datasets | Q34769778 | ||
| Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo. | Q35192675 | ||
| Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors | Q35623459 | ||
| Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector | Q35741984 | ||
| Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. | Q35990696 | ||
| Use of adenoviral vectors as veterinary vaccines | Q36288927 | ||
| Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A | Q36540068 | ||
| Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization | Q36674446 | ||
| Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species | Q36768279 | ||
| Effective induction of high-titer antibodies by viral vector vaccines | Q36770379 | ||
| HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis | Q37413781 | ||
| Viruses as vaccine vectors for infectious diseases and cancer | Q37646066 | ||
| Prime-boost vectored malaria vaccines: progress and prospects | Q37671502 | ||
| Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response | Q39452853 | ||
| Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines | Q39818388 | ||
| Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei | Q40125164 | ||
| Chimpanzee-origin adenovirus vectors as vaccine carriers. | Q40345527 | ||
| Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. | Q40422822 | ||
| Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. | Q40609257 | ||
| Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG | Q41908519 | ||
| Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens | Q42003390 | ||
| Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines | Q42253606 | ||
| Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass | Q43108138 | ||
| CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells. | Q51030167 | ||
| The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. | Q51986133 | ||
| Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. | Q51988630 | ||
| Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. | Q52840563 | ||
| The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens | Q64376607 | ||
| Time-dependent biodistribution and transgene expression of a recombinant human adenovirus serotype 5-luciferase vector as a surrogate for rAd5-FMDV vaccines in cattle | Q64378803 | ||
| Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1 | Q64381481 | ||
| The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 | Q64383973 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| chimpanzee | Q4126704 | ||
| P304 | page(s) | 1121-1128 | |
| P577 | publication date | 2015-01-25 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species | |
| P478 | volume | 33 |
| Q38814885 | Adenoviral vector-based strategies against infectious disease and cancer |
| Q47607706 | Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane |
| Q60046168 | Contributions of Farm Animals to Immunology |
| Q36291682 | Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice |
| Q54234703 | Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate TB Subunit Vaccine. |
| Q36369598 | Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A |
| Q42150824 | Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine |
| Q54531277 | Simian adenoviruses as vaccine vectors. |
| Q42107571 | Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors |
| Q92622099 | Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice |
| Q100466517 | Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines |
| Q40574579 | Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway |
Search more.